|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020792,
umls-concept:C0030705,
umls-concept:C0034866,
umls-concept:C0036849,
umls-concept:C0162791,
umls-concept:C0205210,
umls-concept:C0205313,
umls-concept:C0597198,
umls-concept:C0879290,
umls-concept:C0879389,
umls-concept:C1442518,
umls-concept:C1518321,
umls-concept:C1527075,
umls-concept:C1527249,
umls-concept:C1552652,
umls-concept:C1552685,
umls-concept:C1555306,
umls-concept:C1705195,
umls-concept:C1742737,
umls-concept:C1948033
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-5-15
|
|
pubmed:abstractText |
Identification of individuals who should undergo hereditary nonpolyposis colorectal cancer (HNPCC) genetic testing is a critical and difficult issue. For this purpose, the National Cancer Institute outlined a set of recommendations, the Bethesda guidelines, which have recently been revised.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
pubmed-author:AlendaCristinaC,
pubmed-author:AndreuMontserratM,
pubmed-author:ArgüelloLidiaL,
pubmed-author:BalaguerFrancescF,
pubmed-author:BessaXavierX,
pubmed-author:BujandaLuisL,
pubmed-author:CastellsAntoniA,
pubmed-author:Castellví-BelSergiS,
pubmed-author:CubiellaJoaquinJ,
pubmed-author:Gastrointestinal Oncology Group of the Spanish Gastroenterological...,
pubmed-author:JoverRodrigoR,
pubmed-author:LlorXavierX,
pubmed-author:MorillasJuan DiegoJD,
pubmed-author:PayáArtemioA,
pubmed-author:PiñolVirgíniaV,
pubmed-author:Rodríguez-MorantaFranciscoF,
pubmed-author:XicolaRosa MRM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1104-11
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16696788-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:16696788-Aged,
pubmed-meshheading:16696788-Carrier Proteins,
pubmed-meshheading:16696788-Colorectal Neoplasms,
pubmed-meshheading:16696788-Epidemiologic Studies,
pubmed-meshheading:16696788-Heterozygote,
pubmed-meshheading:16696788-Humans,
pubmed-meshheading:16696788-Middle Aged,
pubmed-meshheading:16696788-MutS Homolog 2 Protein,
pubmed-meshheading:16696788-Mutation,
pubmed-meshheading:16696788-Nuclear Proteins,
pubmed-meshheading:16696788-Practice Guidelines as Topic,
pubmed-meshheading:16696788-Predictive Value of Tests,
pubmed-meshheading:16696788-Prospective Studies,
pubmed-meshheading:16696788-Sensitivity and Specificity,
pubmed-meshheading:16696788-Spain
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
|
|
pubmed:affiliation |
Department of Gastroenterology, Institut de Malalties Digestives, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
